Ambey Laboratories Limited‘s (IPO) opens on July 4, 2024, and closes on July 8, 2024. The allotment for the Ambey Laboratories Limited IPO is anticipated to be completed on Tuesday, July 9, 2024. The IPO will be listed on the NSE and SME, with a tentative date set for Thursday, July 11, 2024.
The price band for the Ambey Laboratories Limited IPO is set at ₹65 to ₹68 per share. The IPO is a book-built issue of Rs 46.68 crores, entirely a fresh issue of 65.52 lakh shares.
Ambey Laboratories IPO Details
| IPO Date | July 4, 2024 to July 8, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹65 to ₹68 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 6,864,000 shares (aggregating up to ₹46.68 Cr) |
| Fresh Issue | 6,864,000 shares (aggregating up to ₹46.68 Cr) |
| Offer for Sale | 312,000 shares of ₹10 (aggregating up to ₹2.12 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Shareholding pre-issue | 18,688,819 |
| Shareholding post issue | 25,240,819 |
| Market Maker portion | 312,000 shares |
Ambey Laboratories IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 2000 | ₹136,000 |
| Retail (Max) | 1 | 2000 | ₹136,000 |
| S-HNI (Min) | 2 | 4,000 | ₹272,000 |
Ambey Laboratories IPO Objectives
The objectives of the Issue are:
- To meet Working Capital Requirements.
- General corporate purposes. Issue-related expenses.
About Ambey Laboratories Limited Company
Ambey Group, founded in 1977, is a diverse conglomerate based in India with interests in FMCG, agrochemicals, and cement sectors. Known for its rapid growth and success, the group offers well-known brands like Anya and A10.
Their manufacturing facility in Behror, Rajasthan, holds ISO 9001:2015 certification from the Quality Research Organization and ISO 14001:2015 certification from the United Accreditation Foundation.
Ambey Laboratories Limited Financial Information
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 8,620.84 | 5,761.85 | 5,592.94 | 4,461.80 |
| Revenue | 10,043.69 | 10,743.47 | 8,511.19 | 8,241.54 |
| Profit After Tax | 607.73 | 456.93 | 357.47 | 1,033.67 |
| Net Worth | 3,431.34 | 2,363.60 | 1,906.67 | -786.39 |
| Reserves and Surplus | 1,562.46 | 588.66 | 131.73 | -1,275.74 |
| Total Borrowing | 2,005.44 | 1,365.22 | 1,804.86 | 3,292.98 |
Ambey Laboratories IPO Timeline
| IPO Open Date | Wednesday, July 4, 2024 |
| IPO Close Date | Monday, July 8, 2024 |
| Basis of Allotment | Tuesday, July 9, 2024 |
| Initiation of Refunds | Wednesday, July 10, 2024 |
| A credit of Shares to Demat | Wednesday, July 10, 2024 |
| Listing Date | Thursday, July 11, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 8, 2024 |
Conclusion
The Ambey Laboratories Limited IPO presents an intriguing opportunity for investors, with its opening on July 4, 2024, and closing on July 8, 2024. The IPO is priced between ₹65 to ₹68 per share, offering a book-built issue of ₹46.68 crores, comprising 65.52 lakh fresh shares. The company aims to utilize the proceeds for working capital requirements, general corporate purposes, and issue-related expenses. With a strong foundation in FMCG, agrochemicals, and cement sectors, Ambey Laboratories boasts a robust financial history and a well-recognized brand portfolio. Investors should mark their calendars for the listing date on July 11, 2024, and consider this IPO for potential gains in a diverse industrial conglomerate.
